Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry).

[1]  O. Alfieri,et al.  Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. , 2012, JACC. Cardiovascular interventions.

[2]  Antonio Colombo,et al.  Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. , 2011, European heart journal.

[3]  J. Blasberg,et al.  The role of gender in coronary surgery. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  M. Jeong,et al.  Randomized trial of stents versus bypass surgery for left main coronary artery disease. , 2011, The New England journal of medicine.

[5]  G. Stone,et al.  Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the "TAXUS Woman" analysis. , 2010, JACC. Cardiovascular interventions.

[6]  M. Jeong,et al.  Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgi , 2010, Journal of the American College of Cardiology.

[7]  O. Alfieri,et al.  5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience. , 2010, JACC. Cardiovascular interventions.

[8]  E. Amsterdam,et al.  Operative mortality in women and men undergoing coronary artery bypass grafting (from the California Coronary Artery Bypass Grafting Outcomes Reporting Program). , 2010, The American journal of cardiology.

[9]  P. Serruys,et al.  A pooled gender based analysis comparing the XIENCE V(R) everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[11]  J. Dery,et al.  Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenarians , 2008, Circulation.

[12]  Young-Hak Kim,et al.  Stents versus coronary-artery bypass grafting for left main coronary artery disease. , 2008, The New England journal of medicine.

[13]  D. Dudek,et al.  Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. , 2008, Journal of the American College of Cardiology.

[14]  S. Ellis,et al.  Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. , 2008, The American journal of cardiology.

[15]  S. de Servi,et al.  A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). , 2007, European heart journal.

[16]  A. Íñiguez,et al.  Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. , 2007, The American journal of cardiology.

[17]  OttavioAlfieri,et al.  Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis , 2006 .

[18]  O. Alfieri,et al.  Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience , 2006, Circulation.

[19]  P. Shah,et al.  Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. , 2006, Journal of the American College of Cardiology.

[20]  P. Serruys,et al.  Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. , 2006, Journal of the American College of Cardiology.

[21]  I. Iakovou,et al.  Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main , 2005, Circulation.

[22]  Seung‐Jung Park,et al.  Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. , 2005, Journal of the American College of Cardiology.

[23]  J. Spertus,et al.  Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial). , 2004, The American journal of cardiology.

[24]  V. Vaccarino,et al.  Sex Differences in Hospital Mortality After Coronary Artery Bypass Surgery: Evidence for a Higher Mortality in Younger Women , 2002, Circulation.

[25]  A. Jacobs,et al.  Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI) , 1998, Circulation.

[26]  W. Weintraub,et al.  Percutaneous transluminal coronary angioplasty in women compared with men. , 1994, Journal of the American College of Cardiology.

[27]  K. Bailey,et al.  The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty. , 1993, JAMA.

[28]  S. Kelsey,et al.  Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. , 1993, Circulation.

[29]  D. Faxon,et al.  One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. , 1989, Circulation.

[30]  S. Kelsey,et al.  Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. , 1985, Circulation.